Pharmacogenetic potential biomarkers for carbamazepine adverse drug reactions and clinical response

Review

Abstract: Carbamazepine (CBZ) is a first-line widely used anticonvulsant. It has a narrow therapeutic index an

Palabras claves:

adverse drug reaction, carbamazepine, Drug resistance, genetic polymorphism, human leukocyte antigen (HLA), pharmacogenetics

Autores:

Adrián LLerena, Cook H.J., Galindo I.F., López M.L., MELANIE BRIGETTE ARROYO LOPEZ, Monroy-Jaramillo N., Vázquez A.O.

Fuentes:

google

scopus